Androgen-induced hepatoma.

No abstract is available for this paper.

• Publication year

  1975

• Venue

  The Lancet

• Publication date

  1975-02-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(75)91494-4PMID 48615
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatoma associated with androgen therapy for aplastic anemia.

  1974cited by this paper
• Androgenic-anabolic steroid therapy and hepatocellular carcinoma.

  1973cited by this paper
• Androgens and hepatocellular carcinoma.

  1973cited by this paper
• Androgenic steroids and hepatocellular carcinoma.

  1973cited by this paper
• Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma.

  1972cited by this paper
• Fanconi's Anaemia in the Genetics of Neoplasia

  1971cited by this paper
• Hepatoma and peliosis hepatis developing in a patient with Fanconi's anemia.

  1971cited by this paper
• Influence of hormones on N-2-fluorenyldiacetamide-induced hyperplastic hepatic nodules in rats.

  1969cited by this paper
• The incidence of spontaneous hepatomas in C3H, C3H (low milk factor), and CBA mice and the effect of estrogen and androgen on the occurrence of these tumors in C3H mice.

  1952cited by this paper

• Current management strategies for sarcopenia and frailty in cirrhosis: Missing link in transplant candidacy

  2026cites this paper
• [Hepatocellular adenomas].

  2025cites this paper
• Treatment of Symptomatic Male Hypogonadism with New Oral Testosterone Therapies: A Comparative Review of Jatenzo, Tlando, and Kyzatrex

  2025cites this paper
• Anabolic Androgenic Steroids and Hepatocellular Adenoma and Carcinoma: Molecular Mechanisms and Clinical Implications

  2024cites this paper
• Transgender Males on Gender-Affirming Hormone Therapy and Hepatobiliary Neoplasms: A Systematic Review.

  2023cites this paper
• Recreational Drugs and the Risk of Hepatocellular Carcinoma

  2022cites this paper
• Pathomolecular characterization of HCC in non-cirrhotic livers

  2020cites this paper
• HCCs and HCAs in Non-cirrhotic Patients: What You See May Not Be Enough

  2019cites this paper
• Male Hypogonadism and Liver Disease

  2017cites this paper
• Scientific and Regulatory Perspectives in Herbal and Dietary Supplement Associated Hepatotoxicity in the United States

  2016cites this paper
• Etiology and Pathogenesis of Hepatocellular Carcinoma: Inflammatory and Toxic Causes

  2016cites this paper
• Testosterone in men with advanced liver disease: Abnormalities and implications

  2015cites this paper
• Hepatocellular Carcinoma in a Noncirrhotic Liver after Long-Term Use of Danazol for Hereditary Angioedema

  2014cites this paper
• Prognostic factors and outcomes after Liver Resection for Hepatocellular Carcinoma in Non-Cirrhotic, Non-Fibrotic Liver.

  2013cites this paper
• Adverse Effects of Hormones and Hormone Antagonists on the Liver

  2013cites this paper
• The Anabolic Androgenic Steroid Oxandrolone in the Treatment of Wasting and Catabolic Disorders

  2012cites this paper
• SPAG16 is a Bifunctional Gene Regulating Male Fertility

  2012cites this paper
• Testosterone: List of Contributors

  2012cites this paper
• Haematogenous abdominal wall metastasis of differentiated, alpha-fetoprotein-negative hepatocellular carcinoma after previous antiandrogen therapy within a site of lipoma manifestation since childhood

  2012cites this paper
• Adverse Drug Reactions: History, Terminology, Classification, Causality, Frequency, Preventability

  2012cites this paper
• Testosterone: Testosterone preparations for clinical use in males

  2012cites this paper
• Benign Liver Tumors

  2011cites this paper
• EIDOS

  2010cites this paper
• Effect of puberty onset on spontaneous hepatitis B virus e antigen seroconversion in men.

  2010cites this paper
• A hepatocellular neoplasm accompanied with massive histiocyte infiltration

  2010cites this paper
• Hepatocellular carcinoma in non-cirrhotic liver: a reappraisal.

  2010cites this paper
• Gene Mutations and Transcriptomic Profiles Associated to Specific Subtypes of Hepatocellular Tumors

  2010cites this paper
• Metabolic Disease and Hepatocellular Carcinoma

  2009cites this paper
• [Is methyltestosterone no longer used therapeutically?].

  2008cites this paper
• steroids in an athlete. Hepatic tumours induced by anabolic

  2008cites this paper
• Androgen receptor concentrations in needle biopsy specimens of human liver.

  2008cites this paper
• Liver pathology associated with the use of anabolic-androgenic steroids.

  2008cites this paper
• Regulation of Globin Gene Expression

  2008cites this paper
• Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma.

  2008cites this paper
• Involvement of Egr-1 in HGF-induced elevation of the human 5alpha-R1 gene in human hepatocellular carcinoma cells.

  2008cites this paper
• Hereditary angioedema: Safety of long-term stanozolol therapy.

  2007cites this paper
• Somatic mutations at the trinucleotide repeats of androgen receptor gene in male hepatocellular carcinoma

  2007cites this paper
• Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level

  2007cites this paper
• The Influence of High Serum Testosterone Levels on the Long-term Prognosis in Male Patients Undergoing Hepatectomy for Early Stage Hepatocellular Carcinoma without Vascular Invasion

  2007cites this paper
• Effects of Surgery Patients with Pitui on Testosterone tary Adenomas Secretion in Male

  2006cites this paper
• Seguimiento de una cohorte de portadores de virus de la hepatitis B: factores de riesgo para la enfermedad hepática crónica

  2005cites this paper
• Suppression of chemically-induced liver tumors by castration or estradiol-3-benzoate treatment in F344 rats.

  2005cites this paper
• Hemangioendothelial sarcoma of the liver associated with long-term estrogen therapy in a man

  2005cites this paper
• Androgens and liver tumors: Fanconi's anemia and non‐Fanconi's conditions

  2004cites this paper
• [Androgen replacement therapy in androgen deficiency in the ageing male].

  2004cites this paper
• Canadian 2003 International Consensus Algorithm For the Diagnosis, Therapy, and Management of Hereditary Angioedema.

  2004cites this paper
• An approach to the surgical pathology of tumours and tumour-like conditions of the liver.

  2004cites this paper
• Danazol-induced hepatocellular carcinoma.

  2003cites this paper
• How do we treat patients with hereditary angioedema.

  2003cites this paper
• Sex hormones and liver cancer.

  2002cites this paper
• Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men.

  2001cites this paper
• C1-inhibitor deficiency and angioedema.

  2001cites this paper
• Liver cancer.

  2001cites this paper
• Drug induced liver disease

  2000cites this paper
• Anabolic steroid-induced hepatic adenomas with spontaneous haemorrhage in a bodybuilder.

  2000cites this paper
• Serum testosterone:estradiol ratio and the development of hepatocellular carcinoma among male cirrhotic patients.

  2000cites this paper
• Epidemiology of hepatocellular carcinoma.

  2000cites this paper
• Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma.

  2000cites this paper
• Evaluation of antiandrogen therapy in unresectable hepatocellular carcinoma: results of a European Organization for Research and Treatment of Cancer multicentric double-blind trial.

  1998cites this paper
• Pharmacology and clinical uses of testosterone

  1998cites this paper
• [Role of sex steroids and their receptors in the pathophysiology of hepatocellular carcinoma].

  1998cites this paper
• Inherent increase of apoptosis in liver tumors: Implications for carcinogenesis and tumor regression

  1997cites this paper
• [Successful therapy of persistent androgen-induced cholestasis with ursodeoxycholic acid].

  1997cites this paper
• Androgen and estrogen-androgen hormone replacement therapy: a review of the safety literature, 1941 to 1996.

  1997cites this paper
• Androgen replacement therapy in women: myths and realities.

  1996cites this paper
• Phase II study of flutamide in the treatment of hepatocellular carcinoma

  1996cites this paper
• Effects of surgery on testosterone secretion in male patients with pituitary adenomas.

  1996cites this paper
• Hepatocellular carcinoma associated with anabolic steroid therapy: Report of a case and review of the Japanese literature

  1996cites this paper
• Micellar electrokinetic capillary chromatographic separation of steroids in urine by trioctylphosphine oxide and cationic surfactant.

  1995cites this paper
• The contribution of hypogonadism to the development of osteoporosis in thalassaemia major: new therapeutic approaches

  1995cites this paper
• Hepatocellular Carcinoma During Hormonotherapy for Prostatic Cancer

  1994cites this paper
• Malignant tumors in two patients with Diamond-Blackfan anemia treated with corticosteroids and androgens.

  1994cites this paper
• Drug-Induced Liver Disease

  1994cites this paper
• Exercise in the Prevention and Treatment of Cancer

  1993cites this paper
• Fatal outcome of a patient with severe aplastic anemia after treatment with metenolone acetate

  1993cites this paper
• Elevated serum testosterone levels and risk of hepatocellular carcinoma.

  1993cites this paper
• Determination of steroids in urine by micellar HPLC with detection by sensitized terbium fluorescence.

  1993cites this paper
• Metabolic effects of anabolic steroids.

  1993cites this paper
• Androgen receptor in cirrhotic liver, adenomatous hyperplastic nodule and hepatocellular carcinoma in the human.

  1992cites this paper
• Hepatitis B virus infection and primary hepatocellular carcinoma

  1992cites this paper
• Endocrinology of Impotence

  1991cites this paper
• Hormonal therapy for hepatocellular carcinoma.

  1991cites this paper
• Analyses of polypeptides in the liver of a novel mutant (LEC rats) to hereditary hepatitis and hepatoma by two-dimensional gel electrophoresis: identification of P29/6.8 as carbonic anhydrase III and triosephosphate isomerase.

  1991cites this paper
• Identifications of Carbonic Anhydrase III and Triosephosphate Isomerase in the Liver Proteins in LEC Rats on Two-Dimensional Gel Electrophoresis

  1991cites this paper
• Nodular Regenerative Hyperplasia, Blood Disorders and Other Uncommon Diseases Associated with Intrahepatic Portal Hypertension

  1991cites this paper
• Androgen associated hepatocellular carcinoma with an aggressive course.

  1991cites this paper
• Enhancement of Athletic Performance with Drugs

  1991cites this paper
• Carcinogenic properties of pharmaceutical agents evaluated in the IARC Monographs programme.

  1991cites this paper
• Treatment of severe aplastic anemia with antilymphocyte globulin and androgens: A report on 33 patients

  1991cites this paper
• Therapeutic indications for delayed puberty and hypogonadism in adolescent boys.

  1991cites this paper
• Testosterone: Action, Deficiency, Substitution

  1990cites this paper
• 3'-Methyl-4-dimethylaminoazobenzenによるラット肝腫瘍誘発におけるMedroxyprogesterone acetateの影響と性ホルモンレセプターの検索

  1990cites this paper
• Safety aspects of androgen therapy

  1990cites this paper
• Recent Developments in the Toxicology of Anabolic Steroids

  1990cites this paper
• Increased cell division as a cause of human cancer.

  1990cites this paper
• Specificity of androgen receptors of hepatocellular carcinoma and liver in humans.

  1990cites this paper
• Danazol-induced hepatocellular adenoma.

  1990cites this paper
• Oral Contraceptives and Neoplasia: 1989 Update

  1989cites this paper
• Drug-induced liver disease.

  1989cites this paper
• Age and sex differences in bone metastasis of hepatocellular carcinoma in Japanese autopsy cases

  1989cites this paper